低危前列腺癌主动监测终止的相关因素:基于人群的研究
该研究基于加拿大安大略省2008至2014年诊断为Gleason评分≤6前列腺癌的男性,描述主动监测(AS)的使用、终止及影响因素。AS使用率从2008年38%升至2014年69%,中位随访48个月后51%患者终止AS。年轻、高合并症、高量医生/机构、较高PSA及癌体积与终止AS相关。
要点
- AS使用率从2008年38%显著升至2014年69%。
- 中位随访48个月,51%患者终止AS,5年无治疗生存率52%。
- 年轻、高PSA、高核心阳性数及高量医生/机构与终止AS相关。
核心结论
- AS使用率随时间显著增加,但5年内终止率较高。
- 向根治性治疗转换的相关因素包括年轻、高量医生/机构、较高PSA及诊断时癌体积较大。
研究设计与样本
- 观察性、基于人群的研究,使用关联行政数据库和病理报告。
- 使用Cochran-Armitage检验分析AS趋势,累积发生率函数估计无治疗生存,Cox比例风险模型评估终止AS的相关因素。
主要发现
- AS作为初始管理策略共8541例(51%)。
- AS使用率从2008年38%显著增至2014年69%(p=0.001)。
- AS患者年龄显著大于初始治疗患者(64岁,SD 8.0 vs 62岁,SD 7.7;p=0.001)。
- 中位随访48个月,4337例(51%)终止AS。
- AS患者1、3、5年无治疗生存率分别为85%、58%、52%;初始AS后至根治性治疗的中位时间16个月(IQR 11-25个月)。
关键数值与推荐
- 终止AS的相关因素:诊断时年轻、诊断年份、更高合并症、学术中心治疗、最高体积三分位医生和机构治疗、不良癌症特征(较高PSA、较高阳性核心数、较高核心受累百分比)。
临床怎么用
- 结果可帮助指导政策制定、开发质量指标,并对开始AS的医生和患者开展针对性继续教育以建立现实期望。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to describe the uptake, discontinuation and variation of active surveillance (AS) by provider and patient level characteristics. MATERIALS AND METHODS: This observational, population-based study used linked administrative databases and pathology reports to identify all men diagnosed with Gleason score ≤6 prostate cancer (PC) between January 1, 2008 and December 31, 2014 in Ontario, Canada. The Cochran-Armitage test was used for AS trend over time. Treatment-free survival was estimated using cumulative incidence function. Factors associated with discontinuation of AS were evaluated using Cox proportional hazard models. RESULTS: Active surveillance was the initial management strategy for 8,541 cases (51%). Use of AS significantly increased from 38% in 2008 to 69% in 2014 (p=0.001). Men on AS were significantly older (64 years, SD 8.0) than those on initial treatment (62 years, SD 7.7; p=0.001). After a median followup of 48 months, 4,337 (51%) patients had discontinued AS. Treatment-free survival for AS patients at 1, 3, and 5 years were 85%, 58% and 52%, respectively. Median time to definitive treatment after initial AS was 16 months (IQR 11-25 months). Factors associated with AS discontinuation were younger age at diagnosis, year of diagnosis, higher comorbidities, treatment at academic center, treatment by physician and institution in the highest volume tertile, and adverse cancer-specific characteristics (higher prostate specific antigen [PSA], higher number of positive cores and higher percentage of core involvement at diagnosis). CONCLUSIONS: Although the uptake of AS significantly increased over time, there has been a relatively high rate of discontinuation over 5 years. Factors associated with transition to definitive treatment were younger age, care provided by higher volume physicians and institutions, higher PSA and greater PC volume at diagnosis. These results may help guide policy making, developing quality indicators, and developing targeted continued education for physician and patients embarking on AS to establish realistic expectations.
引用
- Timilshina N, Komisarenko M, Martin LJ, et al. Factors Associated with Discontinuation of Active Surveillance among Men with Low-Risk Prostate Cancer: A Population-Based Study. J Urol. 2021. PMID: 34412510. doi:10.1097/JU.0000000000001903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。